HeartFlow
heartflow.com
AI-powered cardiac imaging analysis.
Quick Information
- Category:
- Healthcare
- Pricing:
- Contact Sales
- Platforms:
- Web, Cloud, CT scanner workflow
- Free Plan:
- No
- Last Verified:
- October 2026
What Is HeartFlow?
HeartFlow is an AI-powered cardiac imaging company that turns a standard coronary CT angiogram into detailed heart information. Its FFRct Analysis assesses blood flow to help judge whether revascularization would benefit a patient, and Plaque Analysis quantifies and characterizes plaque to help assess risk and manage disease. The platform, called Heartflow One, also includes Roadmap Analysis. The aim is to reduce unnecessary invasive angiograms by giving doctors more from a non-invasive scan.
The business case has strengthened lately. HeartFlow listed on the Nasdaq under the ticker HTFL on August 8, 2025, closing an upsized IPO of about 19.2 million shares at $19 each for roughly $364.2 million in gross proceeds. Shares opened at $28 on the first day. On reimbursement, CMS finalized expanded Medicare coverage for platforms that quantify coronary plaque, including Heartflow's Plaque Analysis, and the AMA issued a new Category I CPT code for them, due to take effect in January 2026. Current stock performance and financials were not part of the sources, so check recent filings. Pricing for hospitals and imaging centres is not public.
HeartFlow suits cardiologists, radiologists and hospitals building a coronary CT programme. Related names are Cleerly, Eko and Aidoc. See the Healthcare tools directory for more.
What Can You Use HeartFlow For?
Coronary blood flow assessment
FFRct Analysis estimates whether revascularization would help.
Plaque quantification
Plaque Analysis characterizes plaque to assess risk.
Chest pain evaluation
Provides more information from a standard coronary CT scan.
HeartFlow Features
- FFRct Analysis — Blood-flow assessment from CT images.
- Plaque Analysis — Quantifies and characterizes coronary plaque.
- Roadmap Analysis — Part of the Heartflow One platform.
- Reimbursement support — Medicare coverage and a new CPT Category I code for plaque analysis.
Who Is HeartFlow For?
- Cardiologists and radiologists — Get functional and plaque insights from CT.
- Hospitals and imaging centres — Offer a coronary CT service with reimbursement.
HeartFlow Pros & Limitations
What We Like
- Publicly traded with a transparent corporate profile
- Medicare coverage and a CPT code support adoption
- Covers both blood flow and plaque
Limitations
- No public pricing
- Current financials and stock performance were not verified
- Relies on quality coronary CT scans
HeartFlow Pricing
| Plan | Price | Main Features |
|---|---|---|
| Provider / hospital | Custom | FFRct Analysis, Plaque Analysis and Roadmap Analysis via Heartflow One |
Pricing was last verified October 2026. Check the official website for the latest pricing.
AI Listing Jungle Ranking
- Global Rank:
- #1007
- Overall Score:
- 37.5/100
- Monthly Users:
- –
- Rank Change:
- ▼ 259
This ranking reflects AI Listing Jungle's own independent scoring methodology and is not an endorsement by HeartFlow or its company. How Our Rankings Work
Frequently Asked Questions
What does HeartFlow do?
It analyses coronary CT scans with AI to assess blood flow and plaque.
Is HeartFlow publicly traded?
Yes, on Nasdaq as HTFL since August 8, 2025.
Is it reimbursed?
CMS finalized expanded Medicare coverage for plaque analysis platforms, and a new CPT Category I code was due in January 2026.
How much does HeartFlow cost?
Pricing is not public.
Our Take
HeartFlow has moved from startup to public company, and the reimbursement tailwinds make adoption easier for hospitals.
Ask about per-scan pricing and workflow fit before committing.
HeartFlow Alternatives
HeartFlow Comparisons
Ready to try HeartFlow?
Visit the official website to get started.
Visit Official WebsiteAI Listing Jungle is an independent AI tools directory. Product names, logos, and trademarks belong to their respective owners.